The Company is a “smaller reporting company” under Item 10 of Regulation S-K promulgated under the Exchange Act and has elected to comply with certain of the requirements applicable to smaller reporting companies in connection with this Annual Report on Form 10-K. Although the rules allow the Company to provide less detail about its executive compensation program, the Compensation and Human Capital Committee is committed to providing the information necessary to help stockholders understand its executive compensation-related decisions. The information below summarizes the executive compensation program and results for our named executive officers (“NEOs”) for Fiscal 2023.
2023 Summary Compensation Table
The following table sets forth information regarding the compensation paid to or earned by the Company’s CEO and our other NEOs, for services rendered to the Company and its subsidiaries for the fiscal years indicated.
| | | | | | | | | | | | | | | | | | | | | |
|---|
| · · · · · · · · · · · · |
|---|
| · · · · · · · · · · Stock · · Non-Equity Incentive · · All Other · · · |
|---|
| · · · · Salary · · Bonus · · Awards · · Plan Compensation · · Compensation · · Total |
|---|
| Name and Principal Position | | Year | | ($) | | ($) | | ($)(1) | | ($)(3) | | ($)(4) | | ($) | |
|---|
| Darren R. Jamison | | 2023 | | | 557,180 | | — | | | | 362,170 | | | — | | | 7,389 | | | 926,739 |
|---|
| President & Chief Executive Officer (5) | | 2022 | | | 545,841 | | — | | | | 362,162 | | | 111,436 | | | 6,445 | | | 1,025,884 |
|---|
| John J. Juric | | 2023 | | | 21,635 | | 100,000 | (2) | | | 220,000 | | | — | | | 666 | | | 342,301 |
|---|
| Chief Financial Officer (6) | | 2022 | | | — | | — | | | | — | | | — | | | — | | | — |
|---|
| Frederick S. Hencken III | | 2023 | | | 69,346 | | — | | | | 150,252 | | | — | | | 3,615 | | | 223,213 |
|---|
| Former Chief Financial Officer (7) | | 2022 | | | 291,125 | | — | | | | 145,004 | | | 27,044 | | | 5,869 | | | 469,042 |
|---|
| (1) | This column represents the aggregate grant date fair value of restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”) granted in the years presented in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, excluding the estimated impact of forfeitures related to service-based vesting conditions. Grant date fair value is calculated using the closing price of Capstone’s common stock on the date of grant. For a discussion of the valuation assumptions, see Note 9 in the Notes to Consolidated Financial Statements. For PRSUs granted in Fiscal 2023, the amount reported in the table above represents the grant date fair value of such award assuming the probable outcome of the performance conditions. The value of such award, assuming the maximum achievement of the performance conditions, is $181,085 for Mr. Jamison. Mr. Hencken forfeited his PRSU award upon his termination of service. Mr. Juric joined the Company in March 2023 and did not receive a PRSU award for Fiscal 2023. |
| (2) | Mr. Juric earned a signing bonus of $100,000 upon joining the Company on March 6, 2023. |
| (3) | This column represents non-equity incentive plan compensation earned pursuant to the Capstone Executive Annual Incentive Plan (the “AIP”). |
| (4) | Amounts reported in this column include Company vacation payouts, Company contributions to the 401(k) plan and premiums paid by the Company for life insurance. |
| (5) | Mr. Jamison departed the Company on August 22, 2023. |
| (6) | Mr. Juric joined the Company on March 6, 2023. |
| (7) | Mr. Hencken departed the Company on July 15, 2022. |
Components and Results of the Fiscal 2023 Executive Compensation Program
The primary components of the compensation program for our NEOs are base salary, annual incentive compensation and long-term incentives and awards. Our NEOs are also eligible for employee benefits consistent with those offered to other employees of the Company and for severance and change in control benefits.
Base Salary* *Base salary is intended to provide a level of assured cash compensation that is competitive in the marketplace to our executive officers. It is based on the individual’s qualifications, experience with the Company, past performance, taking into account all relevant criteria, value to the Company, the Company’s ability to pay and relevant competitive market data. For Fiscal 2023, the Compensation and Human Capital Committee approved the following base salaries:
| · · |
|---|
| · Base Salary at the end · · Base Salary at the end · · |
|---|
| Named Executive Officer | | of 2023 Fiscal Year | | of 2022 Fiscal Year | | % Increase |
|---|
| Darren R. Jamison (1) | | $557,180 | | $557,180 | | 0% |
|---|
| John J. Juric (2) | | $375,000 | | $— | | — |
|---|
| Frederick S. Hencken III (3) | | $300,500 | | $300,500 | | 0% |
|---|
| (1) | Mr. Jamison departed the Company on August 22, 2023. |
| (2) | Mr. Juric joined the Company on March 6, 2023. |
| (3) | Mr. Hencken departed the Company on July 15, 2022. |
Annual Incentive Compensation, Targets and Results The AIP for Fiscal 2023 was designed to focus our NEOs on driving future growth and profitability. Specifically, this plan was designed to reward our NEOs and other senior executives if the Company were to achieve pre-determined total revenue, adjusted EBITDA, and cash provided by working capital targets, subject to the Company’s standard clawback provisions. Target annual incentive opportunities are expressed as a percentage of base salary and were established based on each NEO’s level of responsibility and ability to impact overall results. The Compensation and Human Capital Committee also considers market data in setting target award amounts. Mr. Jamison’s target award opportunity for Fiscal 2023 was 100% of his base salary. Mr. Hencken’s target award opportunity for Fiscal 2023 was 45% of his base salary. Mr. Juric will begin participating in the AIP in Fiscal 2024, and his target award opportunity will be 60% of his base salary. All awards require compliance with the $50.0 million 3-year term note covenants to be eligible for any incentive payout regardless of goal achievement(s). The Compensation and Human Capital Committee also has the discretion to determine if any amendments to the note covenants that have a financial impact on the Company could result in the performance gate/trigger to not have been met.
The weightings for the performance measures for Fiscal 2023 are set forth in the table below.
| · · · · · · · |
|---|
| · · · · · · Cash Provided by |
|---|
| Total · · Adjusted · · Working |
|---|
| Revenue · · EBITDA · · Capital |
|---|
| | 40% | | 40% | | 20% |
|---|
The Fiscal 2023 AIP performance goals were structured to encourage growth:
| · · · · · · · · · · · · · |
|---|
| · Performance Payout Level · · · |
|---|
| Performance Metrics · · Threshold (50%) · Target (100%) · Maximum (150%) · Actual Results(3) · |
|---|
| Revenue (in millions) | | $75.100 | | $80.100 | | $85.100 | | $80.200 | |
|---|
| Adjusted EBITDA (in millions) | | $— | | $0.925 | | $1.850 | | $(6.607) | (1) |
|---|
| Cash provided by working capital (in millions) | | $— | | $1.910 | | $3.820 | | $3.273 | (2) |
|---|
| (1) | Adjusted EBITDA for purposes of the AIP is defined as EBITDA before loss on debt extinguishment, stock-based compensation and other expense, non-recurring legal settlement, reliability repair accrual, and non-recurring legal costs related to settlement and other items determined at the discretion of the Compensation and Human Capital Committee. Refer to page 84 for a reconciliation of Net Loss, as reported to adjusted EBITDA. |
| (2) | Cash provided by the changes in operating assets and operating liabilities of the Company’s working capital accounts for Fiscal 2023 was $3.3 million. |
| (3) | Actual results as presented herein do not reflect the impact of the Restatement. |
On June 13, 2023, the Compensation and Human Capital Committee met to determine if certain performance targets were met under the terms of awards granted for the 2023 Fiscal Year pursuant to the AIP. The Compensation and Human Capital Committee determined that the Company reached slightly above the target level of achievement for the revenue performance criteria and slightly less than the maximum payment for working capital performance criteria, but the performance gate/trigger requiring compliance with the $50.0 million 3-year term note covenants was not met. As such, the Compensation and Human Capital Committee did not authorize non-equity incentive plan compensation payments for Fiscal 2023 pursuant to the AIP. Mr. Juric was appointed at the end of the fiscal year and did not receive an award under this plan for Fiscal 2023.
Long-Term Incentive Targets and Awards* *In discharging its responsibility for administering the Company’s stock-based compensation programs, the Compensation and Human Capital Committee regularly monitors and evaluates the total cost of such programs, based on information provided annually by, and in consultation with, Pearl Meyer, the Company’s independent compensation consultant. This information includes share utilization and annual grant levels. The Compensation and Human Capital Committee determines the appropriate award to each NEO by assessing equity incentive awards made to officers of comparable companies.
Long-term incentive awards are designed to have senior executives focused on the execution of longer-term financial and strategic growth goals that drive stockholder value creation, strengthen our financial position, and support the Company’s leadership retention strategy. At the beginning of Fiscal 2023, Mr. Jamison’s target long-term incentive opportunity was set at 65% of his base salary. Mr. Juric’s target long-term incentive opportunity was set at 60% of his base salary for Fiscal 2024. Mr. Hencken’s target long-term incentive opportunity was set at 50% of his base salary.
| | | | | | | | | | | |
|---|
| · · · · · · |
|---|
| · · Value of Target · · · Value of Target |
|---|
| Executive Officer · · · RSUs Granted(1) · · · PRSUs Granted(1) |
|---|
| Darren R. Jamison (3) | | $181,085 | | | $181,085 | |
|---|
| John J. Juric (2) | | $220,000 | | | $— | |
|---|
| Frederick S. Hencken III (3) | | | $112,689 | | | $37,563 | |
|---|
| | | | | | | | | | | |
|---|
| (1) | Award amounts for RSUs and PRSUs were determined based on the closing price of our common stock on the Nasdaq Capital Market on the date of grant, which was April 7, 2022. The closing price of the common stock on April 7, 2022 was $3.80. |
| (2) | In connection with his appointment as Chief Financial Officer, Mr. Juric received 125,000 RSUs, which will vest on March 6, 2025, provided that Mr. Juric remains employed as Chief Financial Officer on such date. The closing price of the common stock on March 6, 2023 was $1.76. |
| (3) | All unvested grants were forfeited by Mr. Jamison and Mr. Hencken upon their respective departures. |
Outstanding Equity Awards at 2023 Fiscal Year-End
Information about outstanding equity awards held by our NEOs as of the end of Fiscal 2023 is set forth in the table below.
| | | | | | | | | | | | | | | | | | |
|---|
| · · Option Awards · · Stock Awards |
|---|
| | | | | | | | | | | | | | | | Equity Incentive | | Equity Incentive |
|---|
| | | | | | | | | | | | | | | | Plan Awards: | | Plan Awards: |
|---|
| · · · · · · · · · · Number of · · Market Value · · Number of · · Market or Payout |
|---|
| · · Number of Securities · · · · · · Shares or · · of Shares or · · Unearned Shares, · · Value of Unearned |
|---|
| · · Underlying · · Option · · Option · · Units of Stock · · Units of Stock · · Units or Other · · Shares, Units or |
|---|
| · · Unexercised Options · · Exercise · · Expiration · · That Have · · That Have · · Rights That Have · · Other Rights That |
|---|
| · · Exercisable · · Unexercisable · · Price · · Date · · Not Vested · · Not Vested · · Not Vested · · Have Not Vested |
|---|
| Name | | (#)(1) | | (#)(1) | | ($) | | (2) | | (#) | | ($)(3) | | (#) | | ($)(3) | |
|---|
| Darren R. Jamison(10) | | 353 | | — | | 280.00 | | 05/14/2024 | | — | | | — | | 23,827 | (8) | 31,690 |
|---|
| | | — | | — | | — | | — | | — | | | — | | 10,792 | (9) | 14,353 |
|---|
| | | 2,149 | | — | | 184.00 | | 04/09/2023 | | 47,654 | (4) | | 63,380 | | — | | — |
|---|
| | | — | | — | | — | | — | | 14,388 | (5) | | 19,136 | | — | | — |
|---|
| | | — | | — | | — | | — | | 18,580 | (6) | | 24,711 | | — | | — |
|---|
| John J. Juric | | — | | — | | — | | — | | 125,000 | (7) | | 166,250 | | — | | — |
|---|
| (1) | Options vested 25% on the first anniversary of the grant date and monthly thereafter on a pro rata basis over the next 36 months, conditioned on continued service to the Company. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (2) | All options terminate, if not sooner, at the expiration of ten years following the grant date. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (3) | Based on the closing price of our common stock of $1.33 on the Nasdaq Capital Market on March 31, 2023, the last trading day of Fiscal 2023. |
| (4) | These RSUs vest in three equal installments on each anniversary of April 7, 2022, conditioned on continued service to the Company. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (5) | These RSUs vest in three equal installments on each anniversary of April 13, 2021, conditioned on continued service to the Company. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (6) | These RSUs vest in three equal installments on each anniversary of August 27, 2020, conditioned on continued service to the Company. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (7) | These RSUs vest in one installment on March 6, 2025, conditioned on continued service to the Company. However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (8) | These PRSUs are earned based on the achievement of pre-determined Free Cash Flow and Aftermarket Sales Absorption goals measured in the third year of a three-year performance period (2022-2024). However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (9) | These PRSUs are earned based on the achievement of pre-determined Free Cash Flow and Aftermarket Sales Absorption goals measured in the third year of a three-year performance period (2021-2023). However, all grants were cancelled on the Effective Date in connection with Emergence. |
| (10) | Mr. Jamison departed the Company on August 22, 2023 and unvested shares were forfeited upon his departure. |
Employee Benefits Executive officers are generally entitled only to health, welfare and retirement benefits that are consistent with those offered to other employees of the Company. The Company offers group life, disability, medical, dental and vision insurance and an employee stock purchase program. The Company maintains a defined contribution 401(k) profit-sharing plan in which all employees are eligible to participate. The plan also provides for both Company matching and discretionary contributions, which are determined by the Board. The Company matches 50 cents on the dollar up to 6% of the employee’s compensation that is contributed. The Company’s match vests 25% a year over four years starting from the employee’s hire date.
Executive Employment Contracts, Termination of Employment and Change in Control Arrangements
In July 2018, the Company adopted the Capstone Turbine Corporation Amended and Restated Severance Pay Plan (the “Original Severance Plan”). The Original Severance Plan provided that, in the event that a NEO’s employment is terminated by the Company without Cause (as defined in the Original Severance Plan), the NEO would be entitled to receive, subject to the execution of a separation agreement containing a general release of claims, 26 weeks (or 52 weeks in the case of the Chief Executive Officer) of base salary continuation and reimbursement of COBRA premiums for six months (or twelve months in the case of the Chief Executive Officer). In connection with the termination of employment of Mr. Crouse, effective on April 15, 2022, the Company executed a separation agreement with Mr. Crouse providing for twelve months of reimbursement of COBRA premiums. On March 2, 2023, the Company amended the Original Severance Plan (the “Amended Original Severance Plan”) to provide that, in the event that the Chief Financial Officer’s employment is terminated by the Company without Cause, the Chief Financial Officer will be entitled to receive, subject to the execution of a separation agreement containing a general release of claims, 52 weeks of base salary continuation and reimbursement of COBRA premiums for twelve months. The amendment also provides that, in the event that the Chief Executive Officer’s employment is terminated by the Company without Cause, the Chief Executive Officer will be entitled to receive, subject to the execution of a separation agreement containing a general release of claims, 18 months of base salary continuation and reimbursement of COBRA premiums for eighteen months.
On the Effective Date, the Company adopted the Capstone Green Energy Holdings, Inc. Severance Pay Plan (the “New Severance Plan”), which contains terms substantially similar to those set forth in the Amended Original Severance Plan.
Prior to the Effective Date, the Company entered into Change in Control Agreements with each of our NEOs that provide for certain payments and benefits following a termination of the NEO’s employment either by the Company without Cause (as defined in the Change in Control Agreements) (other than due to the NEO’s death, the NEO being Disabled (as defined in the Change in Control Agreements), or the NEO becoming an employee of any direct or indirect successor to the business or assets of the Company, rather than continuing as an employee of the Company) or by the NEO for Good Reason (as defined in the Change in Control Agreements), in either case within six months prior to or 24 months following a Change in Control (as defined in the Change in Control Agreements and such a termination, a “Qualifying Termination”). In the event of a Qualifying Termination, subject to the NEO signing and not revoking a separation agreement containing a general release of claims and a non-disparagement covenant (the “Separation Agreement”), compliance with his or her obligations under the Separation Agreement and compliance with any other continuing obligations to the Company or its successor, the NEO will be eligible to receive (a) a lump sum severance payment equal to 1.0 times (or 1.5 times in the case of Mr. Juric and 2.0 times, in the case of Mr. Jamison) the sum of the NEO’s (i) annual base salary for the calendar year in which the Qualifying Termination occurs (or annual base salary in effect immediately prior to the Change in Control, if higher) and (ii) target annual incentive compensation for the calendar year in which the Qualifying Termination occurs, but pro-rated for the portion of such calendar year that falls prior to the Qualifying Termination; (b) a monthly cash payment in an amount equal to the monthly employer contribution that the Company
would have made to provide health insurance to the NEO if he or she had remained employed by the Company for up to 18 months; and (c) acceleration of any unvested equity awards outstanding on the date of the Qualifying Termination, assuming achievement of performance criteria at target and without reduction for any shortened performance period in the case of performance-based equity awards. Payments under the Change in Control Agreements are in lieu of payments under the Severance Plan. Our recently completed financial restructuring constituted a Change in Control under the Change in Control Agreements. If a NEO experiences a Qualifying Termination within 24 months following such restructuring, such NEO would be eligible to the receive the foregoing severance payments and benefits, as applicable, pursuant to such NEO’s Change in Control Agreement.
On the Effective Date, the Company entered into a Change in Control Agreement with Mr. Juric (the “Effective Date Change in Control Agreement”). The Effective Change in Control Agreement provides for certain payments and benefits following a Qualifying Termination (as defined in the Effective Date Change in Control Agreement). In the event of a Qualifying Termination, subject to such officer’s execution and non-revocation of a Separation Agreement, compliance with such officer’s obligations under the Separation Agreement and compliance with any other continuing obligations to the Company or its successor, such officer will be eligible to receive: (a) a severance payment equal to 1.5 times the sum of such officer’s (i) annual base salary for the calendar year in which the Qualifying Termination occurs (or annual base salary in effect immediately prior to the Change in Control, if higher) and (ii) target annual incentive compensation for the calendar year in which the Qualifying Termination occurs, but pro-rated for the portion of such calendar year that falls prior to the Qualifying Termination; (b) a monthly cash payment in an amount equal to the monthly employer contribution that the Company would have made to provide health insurance to such officer if he or she had remained employed by the Company, for up to 18 months; and (c) acceleration of any unvested equity awards outstanding on the date of the Qualifying Termination, assuming achievement of performance criteria at target and without reduction for any shortened performance period in the case of performance-based equity awards. Payments under the Effective Date Change in Control Agreements are in lieu of payments under the Severance Plan.
In connection with the appointment of Mr. Canino as President and Chief Executive Officer, the Company amended and restated its form Effective Date Change in Control Agreement (the “Amended and Restated Change in Control Agreement”) to revise the definition of “Severance Pay” that will be paid in the event of a Qualifying Termination within the CIC Window (each such term, as defined in the Amended and Restated Change in Control Agreement) to mean an amount equal to a multiple of the sum of the employee’s: (i) annual base salary for the calendar year in which the Date of Termination (as defined in the Amended and Restated Change in Control Agreement) occurs (or the employee’s annual base salary in effect immediately prior to the change in control, if higher); and (ii) target annual incentive compensation for the calendar year in which the Date of Termination occurs. For calculating Mr. Canino’s Severance Pay, the Compensation and Human Capital Committee of the Board approved a multiple of two and one-half (2.5).
The Company has entered into indemnification agreements with its officers and directors containing provisions which may require the Company, among other things, to indemnify its officers and directors against certain liabilities that may arise by reason of their status or service as officers or directors (other than liabilities arising from willful misconduct of a culpable nature) and to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified.
The tables below set forth the amount of compensation payable to each of Messrs. Jamison and Juric, as if each situation occurred on March 31, 2023, under the Severance Plan or Change in Control Agreements discussed above. Mr. Jamison departed the Company on August 22, 2023.
Mr. Jamison
| · · · · · · · |
|---|
| · · Involuntary Termination |
|---|
| · · Involuntary Termination · · · Related to · |
|---|
| Executive Benefits and Payments upon Termination · · without Cause · · Change in Control |
|---|
| Cash Payments | | $557,180 | (1) | $2,228,720 | (2) |
|---|
| RSUs (unvested) | | — | | 252,829 | (3) |
|---|
| Insurance Benefits | | 46,165 | (4) | 69,248 | (5) |
|---|
| Total (6) | | $603,345 | | $2,550,797 | |
|---|
| (1) | Reflects severance payments of Mr. Jamison’s annual base salary as of March 31, 2023 over a period of 52 weeks, payable under the Severance Plan. |
| (2) | Reflects a lump sum severance payment equal to two times the sum of Mr. Jamison’s annual base salary as of March 31, 2023 and target annual incentive compensation, payable under the Change in Control Agreement with Mr. Jamison. |
| (3) | Reflects the value of unvested RSUs and PRSUs that become vested upon a Qualifying Termination, pursuant to the Change in Control Agreement with Mr. Jamison, based on the market value of $1.33 per share on March 31, 2023, the last trading day of Fiscal 2023. In the event of a Qualifying Termination, unvested equity awards outstanding on the date of the Qualifying Termination accelerate and vest in full, assuming achievement of performance criteria at target and without reduction for any shortened performance period in the case of performance-based equity awards. Full vesting is also triggered if the acquirer of the Company does not assume the awards issued under the Capstone Green Energy Corporation 2017 Equity Incentive Plan (the “2017 Plan”). |
| (4) | Reflects monthly payments of health benefit premiums over a period of 12 months, payable under the Severance Plan. |
| (5) | Reflects monthly payments of health benefit premiums over a period of 18 months, payable under the Change in Control Agreement with Mr. Jamison. |
| (6) | Mr. Jamison departed the Company on August 22, 2023. |
Mr. Juric
| · · · · · · · |
|---|
| · · Involuntary Termination |
|---|
| · · Involuntary Termination · · · Related to · |
|---|
| Executive Benefits and Payments upon Termination · · without Cause · · Change in Control |
|---|
| Cash Payments | | $375,000 | (1) | $750,000 | (2) |
|---|
| RSUs (unvested) | | — | | 166,250 | (3) |
|---|
| Insurance Benefits | | 30,365 | (4) | 45,548 | (5) |
|---|
| Total | | $405,365 | | $961,798 | |
|---|
| (1) | Reflects severance payments of Mr. Juric’s annual base salary as of March 31, 2023 over a period of 52 weeks, payable under the Severance Plan. |
| (2) | Reflects a lump sum severance payment equal to two times the sum of Mr. Juric’s annual base salary as of March 31, 2023 and target annual incentive compensation, payable under the Change in Control Agreement with Mr. Juric. |
| (3) | Reflects the value of unvested RSUs and PRSUs that become vested upon a Qualifying Termination, pursuant to the Change in Control Agreement with Mr. Juric, based on the market value of $1.33 per share on March 31, 2023, the last trading day of Fiscal 2023. In the event of a Qualifying Termination, unvested equity awards outstanding on the date of the Qualifying Termination accelerate and vest in full, assuming achievement of performance criteria at target and without reduction for any shortened performance period in the case of performance-based equity awards. Full vesting is also triggered if the acquirer of the Company does not assume the awards issued under the 2017 Plan. |
| (4) | Reflects monthly payments of health benefit premiums over a period of 12 months, payable under the Severance Plan. |
| (5) | Reflects monthly payments of health benefit premiums over a period of 18 months, payable under the Change in Control Agreement with Mr. Juric. |
Director Compensation
On August 24, 2022, each non-employee director received an annual grant of RSUs with a grant date fair value of approximately $50,000, calculated using the closing price of our common stock on the date of grant. These RSUs will become vested upon completion of the annual term of the Board that includes the date of grant.
The director fee schedule for the 2023 Fiscal Year remained unchanged from the previous fiscal year. The director cash retainer was $35,000, the Chair of the Board additional cash retainer was $25,000, and the director equity retainer was $50,000. The Audit Committee Chair retainer was $17,000, the Compensation and Human Capital Committee Chair retainer was $15,000, and the Governance and Sustainability Committee Chair retainer was $10,000. Each non-employee director who served on the Audit Committee received an $8,000 annual retainer. Each non-employee director who served on the Compensation and the Governance and Sustainability Committees received a $5,000 annual retainer. Non-employee directors may elect to receive shares of Common Stock in lieu of any cash retainer, based on the fair market value of Common Stock on the date that cash would have otherwise been paid. All payments are paid quarterly
in arrears. If requested, all director expenses incurred in attending the Board or committee meetings are reimbursed by the Company.
On the Effective Date, the Board adopted a new director compensation policy. Pursuant to the revised director compensation policy, each non-executive director will receive an annual base retainer of $75,000, payable in cash on a quarterly basis. The Audit Committee chair will receive an additional annual retainer of $17,000 and each other Audit Committee member will receive an additional annual retainer of $8,000. The Compensation and Human Capital Committee chair will receive an annual retainer of $15,000 and each other Compensation and Human Capital Committee chair will receive an additional annual retainer of $6,000. The Governance and Sustainability Committee chair will receive an additional annual retainer of $10,000 and each other Governance and Sustainability Committee Chair will receive an additional annual retainer of $6,000. Non-executive directors will also receive an annual grant of $10,000 of restricted stock units, commencing with the 2024 annual meeting of stockholders. On January 22, 2024, the Board approved a policy providing for the grant of 10,000 RSU’s to each new director appointed on or prior to December 7, 2024.
Mr. Jamison, the Company’s former President and Chief Executive Officer, did not receive compensation for serving as a member of the Board. The Company uses its fiscal year in reporting compensation rather than the term of the Board. Compensation amounts may differ between the Company’s fiscal year and the term of the Company’s Board. Information about the compensation of the non-employee directors for the 2023 Fiscal Year is set forth in the table below.
| | | | | | | | | | |
|---|
| · Fees Earned or · Stock · · |
|---|
| Name · · Paid in Cash ($)(1) · · Awards ($)(2) · · Total ($) |
|---|
| Paul DeWeese (3) | | | 10,750 | | | — | | | 10,750 |
|---|
| Robert C. Flexon | | | 68,000 | | | 50,000 | | | 118,000 |
|---|
| Yon Y. Jorden | | | 58,000 | | | 50,000 | | | 108,000 |
|---|
| Robert F. Powelson | | | 51,000 | | | 50,000 | | | 101,000 |
|---|
| Denise M. Wilson | | | 56,000 | | | 50,000 | | | 106,000 |
|---|
| Ping Fu | | | 49,000 | | | 50,000 | | | 99,000 |
|---|
| (1) | For each term of the Board (beginning on the date of an annual meeting of stockholders and ending on the date immediately preceding the next annual meeting of stockholders), a non-employee director may elect to receive a stock award in lieu of all or any portion of his or her annual retainer or committee fee cash payment. The award is calculated by dividing the amount of the fee by the fair market value of a share of common stock on the date the fee is payable. For the 2023 Fiscal Year, due to limited share pool availability, 100% of the amount of the aggregate directors’ fees was paid in cash. |
| (2) | This column represents the aggregate grant date fair value of stock awards granted during the 2023 Fiscal Year calculated in accordance with FASB ASC Topic 718, excluding the estimated impact of forfeitures related to service-based vesting conditions. For a discussion of valuation assumptions, see Note 9 to the Notes to Consolidated Financial Statements. |
| (3) | Mr. Deweese resigned as a Director in March 2022. |
Non-GAAP Measures Reconciliation
Because we disclose Adjusted EBITDA in connection with the disclosure regarding the AIP targets, we have provided the below reconciliation of net loss to Adjusted EBITDA:
| | | | | | | | |
|---|
| · · Year Ended · |
|---|
| Reconciliation of Reported Net Loss to EBITDA and Adjusted EBITDA · · March 31, · |
|---|
| (In thousands) · 2023 · 2022 |
|---|
| Net loss, as reported | | | $(24,522) | | | $(22,370) | |
|---|
| Interest expense | | 6,163 | | 5,004 | |
|---|
| Provision for income taxes | | | 7 | | | 19 | |
|---|
| Depreciation and amortization | | | 3,177 | | | 1,915 | |
|---|
| EBITDA | | | $(15,175) | | | $(15,432) | |
|---|
| | | | | | | | |
|---|
| Loss (gain) on debt extinguishment | | | — | | | (2,610) | |
|---|
| Stock-based compensation and other expense | | | 863 | | | 1,245 | |
|---|
| Non-recurring legal/consulting | | | 1,474 | | | 882 | |
|---|
| Severance | | | 83 | | | — | |
|---|
| Stock to vendors | | | — | | | 1,012 | |
|---|
| Executive bonus | | | 408 | | | 190 | |
|---|
| Adjusted EBITDA | | | $(12,347) | | | $(14,713) | |
|---|